Buy or sell Trace Genomics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Trace Genomics Stock

Advanced prevention and management of agricultural diseases.

Founded

2015

Headquarters

San Francisco CA, US

Total Funding

$22.9M

About Trace Genomics Stock

Their molecular assay for soil and seed-borne pathogens enables affordable detection of hundreds of pathogens and beneficial organisms simultaneously. Their assay is based on genetic sequencing technology, enabling strain-specific identification and quantitation. They use artificial intelligence techniques used in fraud detection and data science to identify microbes and genetic mutations that cause or protect from disease, enabling data-driven insights into soil health and methods to increase crop quality, including yield and shelf life.

Funding History

July 2016$4.0M
February 2017$4.0M
May 2018$14.9M
May 2018$0

Management

Data Scientist

David Stone

Operations Manager

Lisa Becker

Co-Founder & President

Poornima Parameswaran

Microbiome Scientist

Jenna Lang

Co-Founder & CEO

Diane Wu

Senior Scientist

Scott Hickey

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Trace Genomics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo